Clinical Trials Directory

Trials / Unknown

UnknownNCT06335004

Evaluation of Brain Waste Clearance Pathways Using Magnetic Resonance Imaging in Pediatric Patients With White Matter Diseases

Valutazione Delle Vie "Glinfatiche" Utilizzando la Risonanza Magnetica Nelle Malattie Della Sostanza Bianca

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
IRCCS Eugenio Medea · Academic / Other
Sex
All
Age
9 Months – 70 Years
Healthy volunteers
Not accepted

Summary

The dilation of perivascular spaces can be the result of various etiopathogenetic processes. White matter atrophy can cause enlargement of these perivascular spaces (PVS) but also obstruction of fluid drainage systems (interstitial fluid, ISF) and metabolites, as evidenced by some recent studies. Focal stagnation of liquids and deposition of toxic material induce tissue hypoxia and neuroglial dysfunction. Dilation of PVS can be associated with changes in white matter and microhemorrhages. We want to study these etiopathogenetic phenomena by implementing specific MRI methods.

Detailed description

Primary objective: the quantification of indirect magnetic resonance markers of altered waste drainage systems using validated scales in patients with white matter disease. Secondary objective: the evaluation of white matter alterations in relation to the known anatomical glymphatic pathways by analyzing both structural and diffusion data.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic resonance imagingPatients will undergo a magnetic resonance imaging for clinical purposes to which additional sequences. Post gadolinium research sequences will be acquired only if intravenous gadolinium needs to be administered for clinical purposes.

Timeline

Start date
2022-03-01
Primary completion
2024-12-31
Completion
2025-02-28
First posted
2024-03-28
Last updated
2024-03-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06335004. Inclusion in this directory is not an endorsement.